Skip to content

Construction and application of a diagnostic marker for Parkinson's disease based on gut microbiomics

Construction and application of a diagnostic marker for Parkinson's disease based on gut microbiomics

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037239
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Gold Standard:All patients satisfied the United Kingdom Parkinson's Disease Society Brain Bank criteria
gene&#32
detection&#32

Sponsors

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: Primary Parkinson's disease patients,Multi-system atrophy patients.

Exclusion criteria

Exclusion criteria: The presence of other serious disease, malignant tumor, mental disease, dementia.

Design outcomes

Primary

MeasureTime frame
Metagenomics;Metabonomics;Unified Parkinson's disease Rating Scale (UPDRS);gut microbiota;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactQin Xiao

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

xq10537@rjh.com.cn+86 21 64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026